학술논문
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, February 2019, 108:69-77)
Subject
Language
English
ISSN
18790852
09598049
09598049